Cathy Burgess is quoted on how the Food and Drug Administration might conduct remote inspections of drug manufacturing facilities amid COVID-19.
In the News
January 5, 2021
Inside Health Policy | FDA Inspection Plans Unclear as EUAs Move toward Full Approvals
Related News & Insights
-
In the News April 16, 2021Inside Health Policy, Inside Drug Pricing | FDA Lays Out Detailed Plan for Conducting Remote Facility InspectionsCathy Burgess comments on how the U.S. Food and Drug Administration is likely to use remote evaluations to resolve as many issues as possible before returning to onsite inspections of facilities.
-
Health Care Week in Review June 21, 2024Health Care Week in Review: Senate Democrats Released Draft Legislation to Prevent Labor and Delivery Unit Closures; CMS Announced Closure of Accelerated and Advance Payment (AAP) ProgramThis week, Senate Democrats released draft legislation aimed at preventing labor and delivery unit closures, and CMS announced the upcoming closure of the AAP Program that addressed Medicare funding issues resulting from Change Healthcare cyber-attack.
-
Health Care Week in Review April 26, 2024Health Care Week in Review: CMS Finalizes Rules on Nursing Home Staffing Standards and Medicaid Access and Quality; FTC Bans Most Noncompete AgreementsThis week, CMS finalized rules on minimum nursing home staffing standards, as well as access and quality standards in Medicaid, and the Federal Trade Commission (FTC) banned private employers from utilizing most noncompete clauses in employee contracts.
-
Health Care Week in Review April 12, 2024Health Care Week in Review: CMS Releases IPPS Proposed Rule; Congress Holds Hearings on Chronic Care and TelehealthThis week, CMS released the FY2025 Hospital Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital Prospective Payment System (LTCH PPS) Proposed Rule, and Congress held hearings on chronic care and telehealth proposals.
-
Health Care Week in Review October 27, 2023Health Care Week in Review: New House Speaker Elected; HRSA Issued a Notice on 340B Drug Pricing Program RequirementsThis week, members of the House of Representatives elected Representative Mike Johnson (R-LA-4) as the new Speaker and the Health Resources and Services Administration (HRSA) issued a notice of registration requirements for off-site, outpatient hospital facilities to participate in the 340B Drug Pricing Program.
Media Contact
- FDA/Food, Drug & Device
- Life Sciences
- Health Care Legislative & Public Policy
- Chemical & Product Regulation
- Health Care Litigation
- Corporate Compliance Programs
- Biotechnology, Pharmaceutical & Life Sciences Patent Litigation
- Patent Litigation
- Food, Beverage & Agribusiness
- FDA Compliance & Enforcement